MedTrace Logo

Vasovist Magnetic Resonance Angiography (MRA) in Peripheral Arterial Occlusive Disease

NCT00717639 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2011-08-08

No results posted yet for this study

Summary

This study aims at investigating the diagnostic accuracy of magnetic resonance angiography using the contrast agent Vasovist® in the detection of relevant vascular narrowing of the lower extremity. Patients who have been scheduled for intra-arterial conventional angiography are eligible for this trial.

Conditions

  • Peripheral Arterial Occlusive Disease

Interventions

PROCEDURE

Diagnostic MR-Angiography

Single MR-Angiography of the lower extremity after the bolus injection 0.03mmol/kg BW Vasovist

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Henrik J Michaely, MD · Heidelberg University

  • Stefan O Schoenberg, MD · Heidelberg University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00717639 on ClinicalTrials.gov